Insiders / Blume-Jensen Peter
Blume-Jensen Peter
CIK 1950499personinsider
Companies
1
First seen
Jan 16, 2026
Last activity
Mar 3, 2026
Companies
| Company | Shares held | Latest |
|---|---|---|
| Acrivon Therapeutics, Inc. · ACRV | 2,394,331 | — |
All securities held
2 positions · latest reported per filing
| Company | Security | Shares |
|---|---|---|
| Acrivon Therapeutics, Inc. | Common Stock | 2,394,331 |
| Acrivon Therapeutics, Inc. | Stock Option (Right to Buy)Derivative | 602,705 |
Activity
InsidersInstitutions
This person's insider trades (Form 4), across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Jan 14, 2026 | Buy | ACRV Acrivon Therapeutics, Inc. Common Stock | $82.1K | +49K +2.39% | 2,095,771 4.89% of shares | medium |
| Feb 21, 2026 | Other | ACRV Acrivon Therapeutics, Inc. Common Stock | $21.8K | -14K -0.68% | 2,080,204 4.85% of shares | low |
| Feb 14, 2026 | Other | ACRV Acrivon Therapeutics, Inc. Common Stock | $2.1K | -1K -0.06% | 2,094,469 4.89% of shares | low |
| Feb 14, 2026 | Other | ACRV Acrivon Therapeutics, Inc. Common Stock | $944 | -579 -0.18% | 314,127 0.73% of shares | low |
| Mar 1, 2026 | Grant | ACRV Acrivon Therapeutics, Inc. Stock Option (Right to Buy) | — | +185K | 185,495 0.43% of shares | low |
| Mar 1, 2026 | Grant | ACRV Acrivon Therapeutics, Inc. Stock Option (Right to Buy) | — | +417K | 417,210 0.97% of shares | low |